Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Waters

Showing results (411-420 of 418) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 418 results.
JAMA|March 13, 2019
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus ConferenceMarkus M Mueller, Hans Van Remoortel, Patrick Meybohm, et al.
Neurology|September 26, 2001
Genome-wide scan for Parkinson's disease: the GenePD StudyA L DeStefano, L I Golbe, M H Mark, et al.
Neurology|January 10, 2002
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD studyN E Maher, L I Golbe, A M Lazzarini, et al.
Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.
American Journal of Human Genetics|March 29, 2002
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD studyAnita L DeStefano, Mark F Lew, Lawrence I Golbe, et al.
JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 42

Showing results (411-420 of 418) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 418 results.
JAMA|March 13, 2019
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus ConferenceMarkus M Mueller, Hans Van Remoortel, Patrick Meybohm, et al.
Neurology|September 26, 2001
Genome-wide scan for Parkinson's disease: the GenePD StudyA L DeStefano, L I Golbe, M H Mark, et al.
Neurology|January 10, 2002
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD studyN E Maher, L I Golbe, A M Lazzarini, et al.
Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.
American Journal of Human Genetics|March 29, 2002
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD studyAnita L DeStefano, Mark F Lew, Lawrence I Golbe, et al.
JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 42